Skip to main content
Equibles

STATE STREET CORP

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 93751 BOSTON, MA
Back to CRVS Full portfolio

Position in CRVS

as of Jun 30, 2026 · filed Sep 22, 2026
Position Value
$66,842,919
+$14,672,457 QoQ
Shares Held
4,474,091
+25.5% QoQ
Ownership
5.32%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 9% Shared 0% None 91%

Common Shares in CRVS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,949,192,558 across 423 Biotechnology names. CRVS ranks #100 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in CRVS

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $66,842,919 4,474,091
2026-03-31 $52,170,462 3,565,992
2025-12-31 $21,469,317 2,788,223
2025-09-30 $7,416,571 1,006,319
2025-06-30 $2,659,072 664,768
2025-03-31 $731,520 230,038
2024-12-31 $1,099,628 205,538
2024-09-30 $941,138 178,246
2024-06-30 $218,951 120,303
2024-03-31 $214,139 120,303
2023-12-31 $243,589 138,403
2023-09-30 $202,068 138,403
2023-06-30 $316,942 138,403
2023-03-31 $102,468 112,603
2022-12-31 $95,712 112,603
2022-09-30 $92,221 112,603
2022-06-30 $111,476 112,603
2022-03-31 $184,668 112,603
2021-12-31 $241,964 100,400
2021-09-30 $321,376 66,400
2021-06-30 $79,032 29,600